Morphic in the Media
Robert EJ Ryder, MD interviewed at 2018 ADA Annual Meeting on latest EndoBarrier data.
Click the title above to watch the video.
GI Dynamics enrolls first patient in pivotal EndoBarrier trial
Minimally-Invasive, Innovative Therapy Used for Treating Type 2 Diabetes and Obesity U-M expert discusses an upcoming clinical trial involving a new non-invasive, endoscopic weight-loss procedure called the EndoBarrier®.
GI Dynamics continues to turn its story around with UK study.
The EndoBarrier Device for Type 2 Diabetes: What You Need to Know
EndoBarrier – What is the EndoBarrier?
New Devices to Combat Obesity, from Three Boston-Area Firms
GI Dynamics wins FDA nod for pivotal US EndoBarrier trial
Efforts are being made to kick-start further development of a duodenal-jejunal bypass liner, the EndoBarrier (GI Dynamics), this time specifically for use in obese patients with type 2 diabetes, after some issues with the device in earlier trials.
New EndoBarrier tech looks set to rival traditional gastric bypass surgery.
The Guardian reports: “Device that helps obese diabetic lose weight ‘should be rolled out across NHS’”